EGFR and non-small cell lung carcinoma: Despite the various reports on EGFR mutation-positive proportions, it is difficult to estimate the actual disease burden as most studies are not population-based, so little is known about the incidence rates of EGFR mutation-positive and negative non-squamous NSCLC in the general population and in subgroups.